Lung cancer is the most common and the deadliest type of cancer worldwide, with about 221,000 new cases and an estimated 158,000 deaths in 2015 in the U.S., according to the American Cancer Society.
Cigarette smoking is the leading cause of lung cancer, followed by environmental and occupational exposure to pollutants.
A University of Cincinnati (UC) study, published in the advance online edition of the journal Molecular Cancer Therapeutics, provides hope that the therapeutic agent SapC-DOPS could be used for treatment of this cancer.
Xiaoyang Qi, PhD, associate director and associate professor in the Division of Hematology Oncology at the UC College of Medicine and a member of the Cincinnati Cancer Center, the UC Cancer and Neuroscience Institutes and the Brain Tumor Center, says these findings indicate that SapC-DOPS shows promise for treatment of one of the deadliest cancers globally. The findings also provide stronger evidence that this agent could be a key treatment for a variety of cancers.
"I partnered with scientists at Nanjing Medical University in China for this research, as lung cancer in China is a major health issue," Qi says. "As reported by the International Agency for Research on Cancer, more than half of lung cancer deaths caused by air pollutants worldwide occurred in China and other East Asian countries.
"Standard treatment options for lung cancer, including chemotherapy, radiation and surgery, have undesirable side effects that impact the quality of life of the cancer patient, which is why the targeted use of SapC-DOPS could be so beneficial."
SapC-DOPS consists of a lysosomal protein, saposin C (SapC), and a phospholipid named dioleoylphosphatidylserine (DOPS), which are combined and assembled into tiny cavities, or nanovesicles, to target and kill various forms of cancer cells.
Lysosomes are membrane-enclosed organelles that contain enzymes capable of breaking down all types of biological components; phospholipids are major components of all cell membranes and form lipid bilayers--or cell membranes.
Qi and collaborators have previously found that the combination of these two natural cellular components, called SapC-DOPS, caused cell death in many cancer cell types including brain, skin, prostate, blood, breast and pancreatic cancer, while sparing normal cells and tissues.
"Liposomal formulations as vehicles for drug delivery are the subject of intense research," he continues. "Compared with non-encapsulated, free drugs, they provide improved biocompatibility and targeted delivery. Despite promising results in preclinical models of lung cancer and many other cancer types, only a few non-targeted liposomal formulations have been approved for cancer treatment by regulatory agencies. Clinical trials are under way to evaluate some of these in lung cancer patients. However, so far, these liposomes have been shown to be less effective when compared with free drug administration, which is why the SapC-DOPS research is promising as a targeted treatment for lung cancer."
In this study, researchers used SapC-DOPS to selectively target the cell membrane of lung tumors in animal models and in human cell cultures.
Qi says a distinguishing feature of SapC-DOPS is its ability to bind to phosphatidylseriine (PS), a lipid, which is found on the membrane surfaces of all tumor cells.
"To evaluate the role of external cell PS, we evaluated PS exposure in human tumor and non-tumor cells in culture," he says. "We also introduced these cells into animal models and then injected the SapC-DOPS vesicles intravenously to see if we could halt tumor growth."
"Using a double-tracking method in live models, we showed that the nanovesicles were specifically targeted to the tumors. These data suggest that the acidic phospholipid PS is a biomarker for lung cancer, as it has been found to be for pancreatic and brain tumors in previous studies, and can be effectively targeted for therapy using cancer-selective SapC-DOPS nanovesicles."
"We observed that the nanovesicles selectively killed human lung cancer cells, and the noncancerous, or untransformed cells, remained unaffected," Qi continues. "This toxic effect correlated to the surface exposure level of PS on the tumor cells."
Importantly, animals treated with SapC-DOPS showed clear survival benefits and their tumors shrank or disappeared.
"Our results show that SapC-DOPS could be a promising treatment option for lung cancer worthy of further clinical study."
Other collaborators on this study include Shuli Zhao, Yunzhong Nie and Yayi Hou, all affiliated with Nanjing Medical University; Zhengtao Chu, UC and Cincinnati Children's Hospital Medical Center; and Victor Blanco, UC.
This work was supported in part by the National Institutes of Health/National Cancer Institute (1R01CA158372), the New Drug State Key Project (009ZX09102-20) and the Division of Hematology Oncology, University of Cincinnati College of Medicine.
The development and commercialization of this technology has been licensed to Bexion Pharmaceuticals, LLC, in which Qi, holds a minor (less than 5 percent) equity interest. The other authors declared no conflict of interest.
Katie Pence | EurekAlert!
Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center
Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital
Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.
A warming planet
Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.
The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
22.09.2017 | Life Sciences
22.09.2017 | Medical Engineering
22.09.2017 | Physics and Astronomy